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1,25-Vitamin D suppresses 
cholesterol uptake in patients  
with type 2 diabetes 
Oh et al., Circulation advance online publication, 10 August 2009, doi:10.1161/
CIRCULATIONAHA.109.856070
The administration of 1,25-hydroxyvitamin D is associated with 
better survival and lower hospitalization rates in patients with 
end-stage renal disease.1,2 The levels of endogenously produced 
vitamin D in those not receiving pharmacological versions of the 
vitamin are also associated with lower mortality in this popula-
tion.3 Although the benefit appears across multiple causes of death 
and hospitalization,4 the mechanism by which higher vitamin D 
may confer a benefit is unclear.
A new study examines the effects of active vitamin D on 
macrophage cholesterol deposition among cells from patients 
with a variety of metabolic syndromes. Five groups of patients 
were recruited to provide cells: (1) obese, diabetic, hyperten-
sive patients with vitamin D deficiency (25-hydroxyvitamin 
D < 80 nmol/l); (2) obese, diabetic, hypertensive patients 
with normal vitamin D; (3) obese, nondiabetic, hypertensive 
patients with vitamin D deficiency; (4) nonobese, nondiabetic, 
nonhypertensive patients with vitamin D deficiency; and (5) 
nonobese, nondiabetic, nonhypertensive patients without vita-
min D deficiency. Whereas foam cells formed from the mac-
rophages of patients without diabetes as a result of exposure to 
low-density lipoprotein (LDL) cholesterol in each of the two 
media, cells from patients with diabetes cultured in media with 
1,25-dihydroxyvitamin D3 (1,25(OH)2D3) failed to form foam 
cells (Figure). Similarly, the deletion of the vitamin D receptor 
in macrophages from diabetic patients accelerated foam-cell 
formation induced by modified LDL. 1,25(OH)2D3 likely 
prevented oxidized LDL-derived cholesterol uptake through 
the downregulation of c-Jun N-terminal kinase activation, 
reduced peroxisome proliferator-activated receptor-γ expres-
sion, and suppressed CD36 expression. The culturing of cells 
with 1,25(OH)2D3 improved insulin signaling, downregulated 
SR-A1 expression, and prevented oxidized and acetylated LDL-
derived cholesterol uptake. This study suggests that reduced 
vitamin D receptor signaling could be a mechanism by which 
accelerated cardiovascular disease through increased foam-cell 
formation occurs in patients with diabetes mellitus. This could 
therefore be part of the mechanism by which vitamin D is asso-
ciated with better outcomes among patients with kidney disease 
with diabetes.
Lynda Szczech
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Rapamycin extends lifespan in 
genetically heterogeneous mice
Harrison et al., Nature 2009; 460: 392–395; doi:10.1038/nature08221
Rapamycin, known to nephrologists as an immunosuppressive 
agent, has also been noted to have effects on cell growth. At present, 
most of the effects of rapamycin are best explained by inhibition of 
the mammalian target of rapamycin (mTOR) signaling pathway. 
Harrison et al. now examine whether inhibition of mTOR signal-
ing can extend lifespan in a mammalian species. They report that 
rapamycin, an inhibitor of the mTOR pathway, extends median 
and maximal lifespan of both male and female mice fed it begin-
ning at 600 days of age (Figure). Regarding age at 90% mortality, 
rapamycin led to an increase of 14% for females and 9% for males. 
The effect was seen at three independent test sites in genetically 
heterogeneous mice, chosen to avoid genotype-specific effects 
on disease susceptibility. Disease patterns of rapamycin-treated 
mice did not differ from those of control mice. In a separate study, 
rapamycin fed to mice beginning at 270 days of age also increased 
survival in both males and females, on the basis of an interim 
analysis conducted near the median survival point. Rapamycin 
may extend lifespan by postponing death from cancer, by retarding 
mechanisms of aging, or both. This report may be the first to dem-
onstrate a role for mTOR signaling in the regulation of mammalian 
lifespan, as well as pharmacological extension of lifespan in both 
sexes by inhibition of this pathway with rapamycin. Inhibition of 
mTOR by rapamycin has been shown to slow the progression of 
rodent models of PKD. Currently, clinical studies are under way to 
test the effect of rapamycin on the progression of human polycystic 
kidney disease (PKD). So, potentially, the prolonged life can be 
extended to prolonged kidney function in patients with PKD and 
perhaps even other forms of kidney disease. Obviously, many stud-
ies need be performed before this hypothesis can be verified.
Detlef Schlöndorff
Survival plots for male and female mice, comparing control mice with 
those fed rapamycin in the diet starting at 600 days of age, pooling 
across the three test sites.
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1,25(OH)2D3 prevents foam-cell formation. AcLDL, acetylated LDL; 
oxLDL, oxidated LDL.
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Wnt9b signaling in morphogenesis 
of kidney tubules
Karner et al., Nat Genet 2009; 41: 793–799; doi:10.1038/ng.400
Many organs, including the kidney, contain multiple epithelial 
tubules. Diseases that alter tubular shape have significant impact 
on organ function; specifically, defects in the development or main-
tenance of the diameter of nephron tubules cause polycystic kidney 
disease (PKD). During kidney development, the ureteric bud prog-
eny generates the collecting duct tubules, and the more proximal 
part of the tubular nephron derives from the metanephric mesen-
chyme. But very little is known of the mechanisms that establish 
the length or diameter of these tubular segments. In PKD, multiple 
studies have suggested that increased rates of cell proliferation are 
associated with, and may directly cause, cyst formation. However, 
studies in the development of epithelial tubules of worms and flies 
found that cellular processes that are independent of changes in cell 
number greatly impact tubular diameter. The Wnt genes encode a 
family of secreted glycolipoproteins that function in multiple bio-
logical processes, and it is established that tight regulation of Wnt 
signaling is essential for proper development of the kidney tubules. 
Loss of canonical Wnt signaling in mice prevents formation of the 
tubules, and inappropriate activation of the Wnt signal transduction 
pathway leads to cyst formation. In addition, improper stimula-
tion of the canonical Wnt pathway is a hallmark of various types 
of human cystic kidney diseases. During kidney development, 
Wnt9b is needed for the earlier stages of development, acting as 
a paracrine signal from the ureteric bud to initiate metanephric 
mesenchyme tubulogenesis. In a recent communication, Karner et 
al. focused on the role of Wnt9b in renal tubulogenesis. They found 
that mice that were homozygous for a hypomorphic allele of Wnt9b 
(Wnt9bneo/neo) survived for several days to weeks postpartum but 
all died within 1 month of birth. Examination of their kidneys 
revealed severely dilated and cystic tubules (Figure), indicating that 
Wnt9b was required for proper establishment and/or maintenance 
of tubule diameter. The authors also found that nephron tubules 
developed in two distinct phases; during the first phase, cell division 
was not oriented, and the diameter of the epithelium decreased. 
In the second phase, polarized cell divisions predominated, and 
tubule diameter was maintained. Interestingly, Wnt9b regulated 
both phases of development, and, in contrast to its inductive role 
in initial kidney development, its role in tubule morphogenesis was 
mediated by the non-canonical/planar cell polarity signal trans-
duction pathway. Thus, loss of non-canonical Wnt signaling can 
contribute to renal cystogenesis.
Juan Oliver
Variants in the claudin 14 gene 
associate with kidney stones
Thorleifsson et al., Nat Genet 2009; 41: 926–930; doi:10.1038/ng.404
Nephrolithiasis is a very common disorder, with recurrence rates 
of approximately 50% within 5–10 years of the initial event in 
untreated individuals. Most kidney stones contain calcium, whereas 
other forms, including uric acid, struvite, and cystine stones, are 
far less common. Metabolic risk factors can be identified in many 
patients with recurrent disease; idiopathic hypercalciuria is the 
most common risk factor, present in about half of adults with recur-
rent calcium stones. Other rarer abnormalities linked to calcium 
kidney stone formation include hyperoxaluria, hyperuricosuria, 
and hypocitraturia. Both kidney stone disease and primary hyper-
calciuria have a well-recognized family aggregation; about half of 
hypercalciuric stone formers have relatives with nephrolithiasis. 
Calcium stones are also associated with several monogenic mende-
lian traits, many of which affect ion channels and membrane trans-
porters. To search for sequence variants conferring risk of kidney 
stone disease, Thorleifsson et al. recently conducted a genome-wide 
association study. First, 303,120 single-nucleotide polymorphisms 
(SNPs) were tested for association with radiopaque kidney stones 
in a sample of 1507 cases and 34,033 population controls from 
Iceland. Two highly correlated SNPs were located on either side 
of the last exon of the CLDN14 (claudin 14) gene. Next, the two 
variants were examined in 1520 additional Icelandic kidney stone 
cases and 4726 controls, and in 746 kidney stone cases and 3751 
controls from the Netherlands. The two variants were significantly 
associated with kidney stones in both the Icelandic and the Dutch 
replication sets. The authors found that the two variants were non-
exonic SNPs but identified several noncoding and intronic variants, 
as well as two common synonymous SNPs, both located in the 
last and only translated exon of CLDN14, that showed significant 
association with kidney stones in the material sequenced. Claudin 
14 is a member of the claudin family of membrane proteins that 
regulate paracellular passage of ions and small solutes at epithelial 
tight junctions. It has been observed to selectively decrease cation 
paracellular permeability. CLDN11/CLDN14 double-mutant mice 
have mildly increased urine excretion of magnesium and calcium. 
Interestingly, in the work by Thorleifsson et al., the alleles showed 
correlation with lower serum bicarbonate, suggesting a role for 
claudin 14 in acid–base balance. The authors postulate that the 
primary abnormalities associating with the variants in CLDN14 
are decreased serum total bicarbonate and increased urinary cal-
cium, and that kidney stones may be caused by these metabolic 
abnormalities. Regardless of the mechanism, the study shows that 
variants in CLDN14 are associated with kidney stones.
Juan Oliver 
Defects in Wnt9b signaling result in cyst formation. Kidney sections of wild-
type and Wnt9bneo/neo kidneys at E15.5, P1, and P30. Wnt9bneo/neo kidneys 
show signs of cystic dysplasia at P1 and have multiple cysts at 1 month of age.
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